Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gedske Daugaard

Showing results (11-20 of 179) with videos related to

Pageof 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 28, 2011
The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancerMikkel Bandak, Lise Aksglaede, Anders Juul, et al.
International Journal of Cancer|July 13, 2002
Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancerHenrik Lajer, Gedske Daugaard, Anna-Maria Andersson, et al.
Scandinavian Journal of Urology|June 20, 2023
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trialsOscar Lilleby, Peter Meidahl Petersen, Gedske Daugaard, et al.
Health and Quality of Life Outcomes|June 20, 2018
Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancerLouise Bager, Abbey Elsbernd, Aase Nissen, et al.
Urologic Oncology|August 10, 2015
Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?Per Kongsted, Inge Marie Svane, Henriette Lindberg, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2025
Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide studyNiklas B Lindahl, Jakob Lauritsen, Thomas Wagner, et al.
Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II studyAnne Kirstine Hundahl Møller, Karen Damgaard Pedersen, Anita Gothelf, et al.
BJU International|March 1, 2013
Reply: Seminoma stage 1: Patterns of care in EuropeSusanne Osanto, Carla Vossen, Alan Horwich, et al.
Clinical Genitourinary Cancer|October 9, 2018
Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell DysfunctionJulie Wang Skøtt, Jakob Lauritsen, Michael Kreiberg, et al.
BJU International|March 14, 2012
Patterns of care in the management of seminoma stage I: results from a European surveyCarla Y Vossen, Alan Horwich, Gedske Daugaard, et al.
Pageof 18

Showing results (11-20 of 179) with videos related to

Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|June 28, 2011
The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancerMikkel Bandak, Lise Aksglaede, Anders Juul, et al.
International Journal of Cancer|July 13, 2002
Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancerHenrik Lajer, Gedske Daugaard, Anna-Maria Andersson, et al.
Scandinavian Journal of Urology|June 20, 2023
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trialsOscar Lilleby, Peter Meidahl Petersen, Gedske Daugaard, et al.
Health and Quality of Life Outcomes|June 20, 2018
Danish translation and pilot testing of the European Organization for Research and Treatment of Cancer QLQ-TC 26 (EORTC QLQ-TC26) questionnaire to assess health-related quality of life in patients with testicular cancerLouise Bager, Abbey Elsbernd, Aase Nissen, et al.
Urologic Oncology|August 10, 2015
Low-dose prednisolone in first-line docetaxel for patients with metastatic castration-resistant prostate cancer: is there a clinical benefit?Per Kongsted, Inge Marie Svane, Henriette Lindberg, et al.
Acta Oncologica (Stockholm, Sweden)|January 31, 2025
Relapse detection in the Danish surveillance program of patients with clinical stage I seminoma: a nationwide studyNiklas B Lindahl, Jakob Lauritsen, Thomas Wagner, et al.
Acta Oncologica (Stockholm, Sweden)|April 20, 2010
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II studyAnne Kirstine Hundahl Møller, Karen Damgaard Pedersen, Anita Gothelf, et al.
BJU International|March 1, 2013
Reply: Seminoma stage 1: Patterns of care in EuropeSusanne Osanto, Carla Vossen, Alan Horwich, et al.
Clinical Genitourinary Cancer|October 9, 2018
Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell DysfunctionJulie Wang Skøtt, Jakob Lauritsen, Michael Kreiberg, et al.
BJU International|March 14, 2012
Patterns of care in the management of seminoma stage I: results from a European surveyCarla Y Vossen, Alan Horwich, Gedske Daugaard, et al.
Pageof 18